Active Pharmaceutical Ingredient Market

The active pharmaceutical ingredients (API) market is projected to reach USD 199.42 billion by 2031 from USD 149.02 billion in 2026, at a CAGR of 6.0% during the forecast period.

Pfizer Inc. (US), Divi's Laboratories Limited (India), Asymchem (China), Cipla (India), and Evonik (Germany) are the key players in this market.

To know about the assumptions considered for the study download the pdf brochure

These market players have adopted various strategies, including capacity expansions, collaborations, investments, advanced manufacturing, and service development, to strengthen their market positions. In July 2026, Evonik announced a USD 100 million investment to upgrade its drug substance manufacturing site in Tippecanoe, Indiana, US. The investment is designed to expand and modernize manufacturing capabilities for increasingly complex APIs and strengthen the company's drug substance manufacturing capabilities.

In 2026, Pfizer continued to strengthen its API and drug substance manufacturing capabilities through Pfizer CentreOne, its contract development and manufacturing business. Pfizer CentreOne provides services across custom APIs, highly potent compounds, sterile injectables, hormone APIs, and intermediates. Its integrated capabilities span process development, scale-up, analytical support, technology transfer, and commercial manufacturing, strengthening Pfizer's end-to-end API and drug substance offering.

Pfizer Inc. (US): Pfizer Inc. holds a leading position in the active pharmaceutical ingredients (API) market, supported by its global manufacturing infrastructure and broad drug substance capabilities. Through Pfizer CentreOne, the company supports API programs from development through commercial manufacturing. Its capabilities span small-molecule APIs, specialty APIs, steroids, hormones, antibiotics, and intermediates. Pfizer also provides expertise in process development, scale-up, analytical testing, technology transfer, and regulatory support.

Divi's Laboratories Limited (India): Divi's Laboratories is a major global API manufacturer with capabilities across generic APIs, custom synthesis, advanced intermediates, and regulatory starting materials. The company supports customers from process development and optimization through scale-up and commercial manufacturing. Its expertise includes complex chemistry, high-potency compounds, biocatalysis, flow chemistry, particle engineering, milling, and micronization, supported by large-scale manufacturing facilities in India.

Asymchem Inc. (China): Asymchem is a leading pharmaceutical CDMO providing API and intermediate development and manufacturing services from early-stage development through commercial production. Its capabilities include small-molecule APIs, HPAPIs, peptides, oligonucleotides, and pharmaceutical intermediates. The company provides process R&D, optimization, analytical development, scale-up, technology transfer, and commercial manufacturing, supported by advanced continuous-flow and complex chemistry capabilities.

Market Ranking

The active pharmaceutical ingredients (API) market is fragmented, with numerous established and emerging players competing to strengthen their market positions through capacity expansion and integrated API offerings. Key players include Pfizer Inc. (US), Divi's Laboratories Limited (India), Asymchem (China), Cipla (India), and Evonik (Germany). Pfizer supports API development and manufacturing through Pfizer CentreOne, while Divi's Laboratories provides generic APIs and custom synthesis services across multiple therapeutic areas. Asymchem offers integrated CDMO services covering small-molecule APIs, biologics, and complex pharmaceutical products. Cipla manufactures APIs across therapeutic areas, including oncology, respiratory, cardiovascular, and central nervous system products. Evonik provides small-molecule APIs, HPAPIs, intermediates, and drug substance manufacturing services. Collectively, these companies support the market through API development, scalable manufacturing, advanced synthesis, analytical development, GMP manufacturing, and commercial supply capabilities.

Related Reports:

Active Pharmaceutical Ingredients (API) Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech), Potency (HPAPI), Product (mAbs, Hormones, Cytokines), Type of Drug (OTC, Rx), Application (Diabetes, Oncology), Competition - Global forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]